Pub. L. 84-764, tit. II, sec. 202

definitions

EnactedYear: 1956Length: 769 wordsOfficial source
definitions Sec. 202. For the purposes of this title— (1) The term “dangerous drug” means— (A) amphetamine, desoxyephedrine, or compounds or mixtures thereof, including all derivatives of phenolethylamine or any of the salts thereof which have a stimulating effect on the central nervous system, except preparations intended for use in the nose and unfit for internal use; (B) barbituric acid, also known as malonylurea, and its salts and derivatives, and compounds, preparations, and mixtures thereof; (C) other drugs or compounds, preparations, or mixtures thereof which the Commissioners shall find and declare by rule or regulation duly promulgated, after reasonable public notice and opportunity for a hearing to be habit-forming, excessively stimulating, or to have a dangerously toxic, or hypnotic or somnifacient effect on the body of a human or animal; except that the term “dangerous drug” shall not include any drug the manufacture or delivery of which is regulated by Federal narcotic drug laws, or by the narcotic drug laws of the District of Columbia. (2) The terms “delivery” and “furnish” mean the selling, dispensing, giving away, sampling, or supplying in any other manner. (3) The term “patient” means, as the case may be— (A) the individual for whom a dangerous drug is prescribed, administered, or supplied in the course of professional practice for a legitimate medical purpose ; or (B) the owner or the agent of the owner of the animal for whom a dangerous drug is prescribed or to which or on which a dangerous drug is administered or used in the course of professional practice for a legitimate medical purpose. (4) The term “person” includes any corporation, partnership, association, or one or more individuals, acting either as principal or agent. (5) The term “practitioner” means any person duly licensed by appropriate authority and, in conformance with the law, licensed to prescribe dangerous drugs, and to administer and use dangerous drugs in the course of his professional practice. (6) The term “pharmacist” means a person duly licensed as a pharmacist pursuant to the Act approved May 7, 1906, as amended (title 2, ch. 6, D. C. Code, 1951 edition). (7) The term “prescription” means a written or oral order by a practitioner to a pharmacist for a dangerous drug for a particular patient, which specifies the date of issue, the name and address of the patient (and, in the case of prescription for an animal, the species of such animal), the name and quantity of the dangerous drug prescribed, the directions for use of such drug, and in case of a written 70 Stat. 613order, the signature and office address of such practitioner, and in the case of an oral order, the District of Columbia or State registration number and office address of such practitioner (and if the practitioner be a member of the Armed Forces of the United States, then he shall give his rank, serial number, and station). Each oral order by a practitioner for a dangerous drug must be promptly reduced to writing by the pharmacist. (8) The term “hospital” means an institution or dispensary or clinic for the care and treatment of the sick and injured, approved by the Commissioners as proper to be entrusted with the custody of dangerous drugs and the professional use of dangerous drugs under the direction of a physician, dentist, or veterinarian. (9) The term “laboratory” means a laboratory approved by the Commissioners as proper to be entrusted with the custody of dangerous drugs and their use for medical and scientific purposes, and for purposes of instruction. (10) The term “manufacturer” means a person or persons, other than pharmacists and practitioners who manufacture dangerous drugs, and includes persons who prepare such drugs in dosage forms by mixing, compounding, encapsulating, entableting, or other process, or who repackage such drugs. (11) The term “wholesaler” means a person or persons engaged in the business of distributing dangerous drugs to persons included in any of the classes named in subdivisions (A) end (D), inclusive, of section 205. (12) The term “drug salesman” or “manufacturer’s representative” means any person who, acting in the course of his regular duties, calls upon or visits practitioners or pharmacists in the interest of demonstrating, selling, or detailing the use and sale of dangerous drugs. (13) The term “warehouseman” means a person who, in the usual course of business, stores drugs for others lawfully entitled to possess them, and who has no control over the disposition of such drugs except for the purpose of such storage. (14) The term “Commissioners” means the Commissioners of the District of Columbia, sitting as a board, or their designated agent or agents.
Pub. L. 84-764, tit. II, sec. 202: definitions | Justis AI